Detalhe da pesquisa
1.
Potential competing risk of death in older high-risk endometrial carcinoma patients: Results from a multicentric retrospective cohort.
Gynecol Oncol
; 166(2): 269-276, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35643579
2.
Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma.
Bull Cancer
; 109(2S): 2S31-2S38, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35760468
3.
[New drugs approval: Trastuzumab-deruxtecan - HER2-low metastatic breast cancer]. / Nouvelles AMM : trastuzumab-deruxtecan cancer du sein métastatique HER2-faible.
Bull Cancer
; 110(6): 597-598, 2023 06.
Artigo
Francês
| MEDLINE | ID: mdl-37045733